Study revealed the possible cause of pancreatic cancer. The findings hold implications for the targeted treatment of pancreatic ductal adenocarcinoma (PDAC), which accounts for the vast majority of all pancreatic tumors and is the fourth-leading cause of cancer-related deaths worldwide.
For patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer by freezing - called cryoablation - yields a lower-risk of cancer-related death compared to heat-based thermal ablation, reports a preliminary study in T
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells. Recent advances in cancer treatment have focused on developing immune c
Washington State University-led research indicates that a common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors.
Appendiceal cancer (malignancies of the appendix, a small tissue pouch that is part of the gastrointestinal tract) is very rare, occurring in perhaps one or two people per 1 million per year. Prognoses are mixed, with a 5-year survival rate of 67 to 97 per cent for low-grade tumours detected
Radiotherapy has become a crucial part of breast cancer treatment, it can also have a severe influence on patients' quality of life, including their emotional, physical, and social wellbeing. It can also cause cancer-related fatigue.
Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.
Breast cancer is the most common form of the disease among women; in Australia, one in eight women will be diagnosed with breast cancer by the age of 85.
Radiotherapy has emerged as an important component of breast cancer treatment but can lead to cancer-related fatigue and negatively impac
Scientists at the Garvan Institute of Medical Research have identified molecular profiles of the surrounding matrix of a common type of lung cancer that might indicate which patients are likely to develop aggressive tumours.
ADCs, or antibody drug conjugates, are a class of complicated cancer treatments that have undergone extensive testing in clinical studies. The study explained the potential hazards related to these drugs.